联康生物科技集团(00690.HK)拟8月28日举行董事会会议批准中期业绩

Core Viewpoint - The company, Lian Kang Biotechnology Group (00690.HK), has announced a board meeting scheduled for August 28, 2025, to approve its interim financial results for the six months ending June 30, 2025 [1] Group 1 - The board meeting will take place at the company's registered office [1] - The meeting will include the approval of financial performance for both the company and its subsidiaries [1]